Pathoblockers or antivirulence drugs as a new option for the treatment of bacterial infections

Scholarly Works

• Beshr, G.; Sikandar, A.; Gläser, J.; Fares, M.; Sommer, R.; Wagner, S.; Köhnke, J.; Titz, A. A fucose-binding superlectin fromEnterobacter cloacaewith high Lewis and ABO blood group antigen specificity. Cold Spring Harbor Laboratory 2024. doi:10.1101/2024.10.01.616118
• Metelkina, O.; Konstantinović, J.; Klein, A.; Shafiei, R.; Fares, M.; Alhayek, A.; Yahiaoui, S.; Elgaher, W. A. M.; Haupenthal, J.; Titz, A.; Hirsch, A. K. H. Dual inhibitors of Pseudomonas aeruginosa virulence factors LecA and LasB. Chemical science 2024, 15, 13333–13342. doi:10.1039/d4sc02703e
• Chen, P.; Qin, J.; Su, H. K.; Du, L.; Zeng, Q. Harmine acts as a quorum sensing inhibitor decreasing the virulence and antibiotic resistance of Pseudomonas aeruginosa. BMC infectious diseases 2024, 24, 760. doi:10.1186/s12879-024-09639-9
• Anjum, F.; Hazazi, A.; Alsaeedi, F. A.; Bakhuraysah, M.; Shafie, A.; Alshehri, N. A.; Hawsawi, N.; Ashour, A. A.; Banjer, H. J.; Alharthi, A.; Niaz, M. I. Identification and Dynamics Understanding of Novel Inhibitors of Peptidase Domain of Collagenase G from Clostridium histolyticum. Computation 2024, 12, 153. doi:10.3390/computation12080153
• Butler, M. S.; Vollmer, W.; Goodall, E. C. A.; Capon, R. J.; Henderson, I. R.; Blaskovich, M. A. T. A Review of Antibacterial Candidates with New Modes of Action. ACS infectious diseases 2024, 10, 3440–3474. doi:10.1021/acsinfecdis.4c00218
• Moulding, P. B.; El-Halfawy, O. M. Chemical-mediated virulence: the effects of host chemicals on microbial virulence and potential new antivirulence strategies. Canadian journal of microbiology 2024, 70, 405–425. doi:10.1139/cjm-2024-0017
• Olaru, O. T.; Nitulescu, G. M.; Codreanu, A. M.; Calmuc, V.-A.; Venables, L.; van de Venter, M.; Gird, C. E.; Duta-Bratu, C.-G.; Nitulescu, G. Inhibitory Effects on Staphylococcus aureus Sortase A by Aesculus sp. Extracts and Their Toxicity Evaluation. Plants (Basel, Switzerland) 2024, 13, 1405. doi:10.3390/plants13101405
• Lobertti, C. A.; Gizzi, F. O.; Magni, C.; Rial, A.; Chabalgoity, J. A.; Yim, L.; Blancato, V. S.; Asquith, C. R. M.; García Véscovi, E. Enhancing colistin efficacy against Salmonella infections with a quinazoline-based dual therapeutic strategy. Scientific reports 2024, 14, 5148. doi:10.1038/s41598-024-55793-0
• El-Soudany, I.; Attia, N.; Emad, R.; Rezk, S. The Effect of Citric and Ascorbic Acids as Anti-Biofilm and Anti-Capsular Agents on Multidrug-Resistant Acinetobacter baumannii. Medical principles and practice : international journal of the Kuwait University, Health Science Centre 2024, 33, 281–290. doi:10.1159/000537852
• Alenazi, N. A.; Aleanizy, F. S.; Alqahtani, F. Y.; Aldossari, A. A.; Alanazi, M. M.; Alfaraj, R. Anti-quorum sensing activity of poly-amidoamine dendrimer generation 5 dendrimer loaded kinase inhibitor peptide against methicillin-resistant Staphylococcus aureus. Saudi pharmaceutical journal : SPJ : the official publication of the Saudi Pharmaceutical Society 2023, 32, 101932. doi:10.1016/j.jsps.2023.101932
• Konstantinović, J.; Kany, A. M.; Alhayek, A.; Abdelsamie, A. S.; Sikandar, A.; Voos, K.; Yao, Y.; Andreas, A.; Shafiei, R.; Loretz, B.; Schönauer, E.; Bals, R.; Brandstetter, H.; Hartmann, R. W.; Ducho, C.; Lehr, C.-M.; Beisswenger, C.; Müller, R.; Rox, K.; Haupenthal, J.; Hirsch, A. K. H. Inhibitors of the Elastase LasB for the Treatment of Pseudomonas aeruginosa Lung Infections. ACS central science 2023, 9, 2205–2215. doi:10.1021/acscentsci.3c01102
• Zaman, N.; Azam, S. S. Discrete Dynamics of Warhead Modulation on Covalent Inhibition of Oxyr: A QM/MM Study. The journal of physical chemistry. B 2023, 127, 5993–6005. doi:10.1021/acs.jpcb.2c07376
• Hardy, E.; Sarker, H.; Fernandez-Patron, C. Could a Non-Cellular Molecular Interactome in the Blood Circulation Influence Pathogens' Infectivity?. Cells 2023, 12, 1699. doi:10.3390/cells12131699
• Leusmann, S.; Ménová, P.; Shanin, E.; Titz, A.; Rademacher, C. Glycomimetics for the inhibition and modulation of lectins. Chemical Society reviews 2023, 52, 3663–3740. doi:10.1039/d2cs00954d
• Gerling-Driessen, U. I. M.; Hoffmann, M.; Schmidt, S.; Snyder, N. L.; Hartmann, L. Glycopolymers against pathogen infection. Chemical Society reviews 2023, 52, 2617–2642. doi:10.1039/d2cs00912a
• Savitskii, M. V.; Moskaleva, N. E.; Zigangirova, N. A.; Soloveva, A. V.; Sheremet, A. B.; Bondareva, N. E.; Lubenec, N. L.; Pyatigorskaya, N. V.; Appolonova, S. A. Experimental Pharmacokinetics, Metabolism and Tissue Distribution Studies Fluorothiazinon, a of Novel Antivirulence Drug. Journal Biomed 2023, 19, 73–84. doi:10.33647/2074-5982-19-1-73-84
• Empting, M. Quo vadis quorum sensing? Advances in disrupting the Pseudomonas quinolone signal (PQS). New Approaches Towards Novel Antibacterial Agents; Elsevier, 2023; pp 135–159. doi:10.1016/bs.armc.2023.09.004
• Walesch, S.; Birkelbach, J.; Jézéquel, G.; Haeckl, F. P. J.; Hegemann, J. D.; Hesterkamp, T.; Hirsch, A. K. H.; Hammann, P.; Müller, R. Fighting antibiotic resistance-strategies and (pre)clinical developments to find new antibacterials. EMBO reports 2022, 24, e56033. doi:10.15252/embr.202256033
• Kuhaudomlarp, S.; Imberty, A. Involvement of sialoglycans in SARS-COV-2 infection: Opportunities and challenges for glyco-based inhibitors. IUBMB life 2022, 74, 1253–1263. doi:10.1002/iub.2692
• Mała, P.; Siebs, E.; Meiers, J.; Rox, K.; Varrot, A.; Imberty, A.; Titz, A. Discovery of N-β-l-Fucosyl Amides as High-Affinity Ligands for the Pseudomonas aeruginosa Lectin LecB. Journal of medicinal chemistry 2022, 65, 14180–14200. doi:10.1021/acs.jmedchem.2c01373

Explore citations to this article at